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1. Introduction 
Type-2 diabetes mellitus (T2DM) is a complex disease with multiple causes covering several 
functional entities of the metabolism. Environmental factors contribute to the pathogenesis 
of the disease – most notably nutrition and weight of the organism. The identification of 
disease genes is the driving power of many research projects. In a previous paper (Rasche et 
al. 2008) we presented a method that integrates results from different T2DM related studies 
and identifies candidate genes with high disease relevance. This chapter is designated to 
elaborate on our work from a network based perspective. Network biology is a promising 
field that can shed light on interrelations between disease genes and from disease genes to 
their functional neighborhood. We use network-based tools to advance from a single-gene 
analysis towards a subnet, a functional module, of disease genes. 
Proteins are gene products that are associated with particular molecular functions. 
Molecular functions are interpreted as activities that can be performed by individual 
proteins following the definitions introduced by the Gene Ontology Consortium (Ashburner 
et al. 2000). Examples of molecular functions are catalytic activity, transporter activity or 
binding. Additionally, a biological process is accomplished by one or more ordered 
assemblies of molecular functions (Ashburner et al. 2000). 
Proteins physically interact with each other in order to carry out a biological function. A 
biological function is related to the term biological process. A signal transduction cascade 
whose biological function is to transmit information from a receptor to a transcription factor 
is a succession of protein-protein interactions (PPIs). Both the molecular function of a 
protein and the biological function in which it is involved are best deduced by studying the 
environment where it operates in. 
To this end, scientists pursue the ambitious goal of assembling all PPIs in an organism – the 
interactome – to elucidate how proteins work together and promote individual biological 
processes and eventually the complete cellular machinery. Today, mainly two methods are 
used to detect PPIs: Yeast two-hybrid screens (Fields & Sternglanz 1994) and affinity 
purification (Pandey & Mann 2000). These large-scale technologies provide vast numbers of 
interactions but have high false positive rates. Additionally, such experiments only reflect 
one environmental condition and not the dynamics of interactions between different 
phyiological states leading to high false negative rates. 
Regarding the current size of the human interactome, we have only a draft of the complete 
set of interactions. However, looking at the course of construction (fig. 1) so far and bearing 
in mind new quality standards we are continuously moving towards the completion of a 
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comprehensive human PPI network. For now we have to take into account that the network 
is incomplete and noisy. 
 
 
Fig. 1. Cumulative number of detected PPIs of the last years. The data is taken from the 
ConsensusPathDB website. The data may contain false positive interactions. 
Interactions are consolidated in many different databases. For further analysis we take 
advantage of ConsensusPathDB (Kamburov et al. 2009; Kamburov et al. 2011), a resource 
joining various human molecular interaction networks including protein-protein, metabolic, 
signaling and gene regulatory interaction networks. ConsensusPathDB integrates 
interaction data from many interaction databases, consequently providing us with a 
comprehensive resource of the currently known interactome. 
2. Meta-analysis 
T2DM is a polygenic disease subject approached by diverse studies using a variety of 
experimental methods to dissect the molecular basis of T2DM. In Rasche et al. (2008) we 
conducted a meta-analysis approach merging different heterogeneous data sources for the 
identification of disease candidate genes. The analysis included transcriptome studies from 
multiple tissues in mouse and human, genetic information using knock-out mice, text 
mining as well as signaling protein data.  
We computed scores for all genes in each individual study and summarized the scores 
across the different studies. Thus a basic disease relevance score was established. 
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Comparing the aggregated scores against a bootstrap background sample defined a cut-off 
score. Using this threshold, a list of 213 candidate genes was identified. The set of candidate 
genes was related to different T2DM gene predictions, monogenic mouse models for T2DM 
and major association studies with considerable overlap. These overlaps showed clearly that 
gene lists can be generated relying on a single aspect or technology but our meta-analysis 
rather encompasses a broad range of biomolecular aspects of T2DM. Functional enrichment 
analyses for KEGG pathways revealed a tight connection with diabetes-specific pathways. 
However, some genes exhibit a higher interconnection and contribute to an extensive 
crosstalk between Insulin signaling, Type II diabetes mellitus and PPAR signaling. Several 
candidate genes in particular are hubs in the protein interaction networks with many 
interactions and linking several of the pathways. 
With the set of candidate genes we identified biological networks on different layers of 
cellular information: Signaling and metabolic pathways, gene regulatory networks and 
protein-protein interaction networks. However, we only provided parts of different 
networks as separated results. In this study the 213 candidate genes and their respective 
gene scores are used to identify a subnetwork of the human interactome provided over 
several functional levels by the ConsensusPathDB. 
3. PPI networks 
From a mathematical point of view proteins can be described as nodes (vertices) and 
interactions can be described as undirected links (edges) between interacting proteins. 
This abstraction allows us to characterize PPI networks by mathematical means. It helps 
to uncover underlying organizing principles of biological networks, describing the role of 
proteins in terms of topological parameters. Although computational methods are 
impaired by incomplete data sets they could be used to point out crucial proteins and 
structures.  
Local topological properties characterize single proteins in a PPI network and may be 
averaged over all proteins. We give short definitions for the most common topological 
properties. More detailed descriptions can be found on the website introducing the Network 
Analyzer plug-in (Assenov et al. 2008). The defined topological parameters are computed in 
the Cytoscape (Cline et al. 2007) environment using the Network Analyzer plug-in and 
summary distributions are visualized in fig. 2 and 3. 
Degree: The node degree of a node n is equal to the number of nodes that interact with node 
n. 
Neighborhood connectivity: The connectivity of a node n is equal to its node degree. The 
neighborhood connectivity of a node n is defined as the average node degree of all 
neighbors of n. 
Clustering coefficient: The clustering coefficient is a ratio between the number of edges 
between the neighbors of n, and the maximum number of edges that could possibly exist 
between the neighbors of n. 
Betweenness centrality: The betweenness centrality of a node n equals the fraction of shortest 
paths (excluding paths starting or finishing in n) in a network that pass through the node n. 
A shortest path between two nodes corresponds to the minimal number of edges that has to 
be traversed in the graph to get from one node to the other. 
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Fig. 2. Topological parameters are computed for five random PPI networks. Initial 
number of nodes is 12733. The probability for a node being part of the network is 0.01. 
The computation was done with igraph (Csardi & Nepusz 2006). Abbrv.: CC, clustering 
coefficient. 
 
 
Fig. 3. Topological parameters for the ConsensusPathDB PPI network with 12733 nodes and 
101613 undirected interactions  
Global network properties emerge from the sum of all local topological properties and 
follow well-defined organizing principles (Barabási & Oltvai 2004): 
Degree distribution: The degree distribution returns the probability that a randomly selected 
node is connected to k other nodes. 
Average clustering coefficient distribution: The average clustering coefficient distribution 
returns the average over the clustering coefficients of all nodes with the same node degree k. 
Shortest paths distribution: Considering all possible shortest paths in the network, the shortest 
paths distribution gives for each attained shortest path length the number of node pairs 
having such a path length. 
These graph-theoretical criteria are important to show that biological networks are not 
comparable with random graphs following the well established Erdős–Rényi model (Erdős 
& Rényi 1960) since it does not sufficiently capture the wiring principles of PPI networks. In 
random graphs most nodes have approximately the same number of neighbors. In PPI 
networks there are only a few highly connected nodes called hubs. Most nodes only have a 
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few neighbors. This property is described by scale-free networks (Barabasi & Albert 1999) 
whose node degree distribution follows a power-law. Additionally, PPI networks have 
properties of “small-world” networks (Watts & Strogatz 1998): PPI networks exhibit a high 
degree of clustering and small path lengths between nodes. Modularity, a high degree of 
clustering and a degree distribution following a power law account for a hierarchical 
organization of the PPI network (Ravasz & Barabási 2003).  
We build a PPI network from the set of PPIs in the ConsensusPathDB. We map genes to 
their respective protein identifiers and draw the parameter distributions for all candidate 
genes as well as for the total set of genes which are part of the PPI network (control). We 
want to quantify to which extent candidate genes separate from the whole network. 
Following Xu & Li (2006) we computed: 
1N index: The 1N index is the ratio between the number of interactions with candidate genes 
and the number of all interactions for a given node n. 
2N index: The 2N index is the average over all 1N indexes for interaction partners of node n.  
Average distance to candidate genes: The average distance to candidate genes is the average 
over the shortest paths from a given node n to all candidate genes. 
Positive topological coefficient: The positive topological coefficient is the average over the 
number of shared neighbors with any candidate genes. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Degree distributions and neighborhood connectivity distributions for candidate genes 
and all genes displayed on a log scale. 
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Fig. 5. Clustering coefficient distributions and betweenness centrality distributions for 
candidate genes and all genes displayed on a log scale. 
 
 
 
 
 
 
Fig. 6. Average distance to candidate genes distributions and positive topological coefficient 
distributions for candidate genes and all genes displayed on a log scale. 
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Fig. 7. 1N index distributions and 2N index distributions for candidate genes and all genes 
displayed on a log scale. 
Distributions of the parameters are on display in fig. 4-7. In order to assess the significance 
of the distributions difference in the means parameter distributions for candidate genes and 
control we use the Wilcoxon rank sum test; resulting p-values are listed in table 1. For the 
degree, betweenness centrality, 2N index and average distance to candidate genes a 
significant deviation from the complete PPI network is ascertained. 
 
Parameter H0 H1 p-value 
Degree A = B A > B 2.038e-10 
Neighborhood Connectivity A = B A > B 0.1103 
Clustering coefficient A = B A > B 1 
Betweenness Centrality A = B A > B 2.563e-08 
1N index A = B A > B 0.1439 
2N index A = B A > B < 2.2e-16 
Positive topological coefficient A = B A > B 0.9999 
Average distance to candidate genes A = B A < B 3.038e-12 
Table 1. Results for Wilcoxon rank sum test: A – distribution for candidate genes, B – 
distribution for all genes, H0 – null hypothesis, H1 – alternative hypothesis. 
4. Functional modules 
Proteins that form a local neighbourhood, topological module, and share a biological function 
can be summarized in a functional module. Following the interpretation that a disease results 
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as a consequence of a disrupted or disturbed functional module, such a module represents the 
fingerprint of a disease – the disease module (Barabási et al. 2011). The close relationship 
between topology, functionality and disease relevance demands for algorithms which can 
decompose the PPI network into distinct subnetworks. We want to identify a subnetwork 
(module) with high disease relevance.  
As interaction data encodes only topological information we need to incorporate 
biological data which provides information on genes that are for example differentially 
expressed in the course of a disease and points to irregularities in biological function. 
Additionally, expression data provides temporal and spatial information. With the set of 
measured genes or proteins we build a node induced network containing the measured 
proteins and their interactions.  
Finding a subnetwork of high disease relevance was first addressed by Ideker et al. (2002). 
The solution to the raised problem involves the following two steps: First, nodes in the 
network are weighted according to some criteria, usually according to their degree of 
differential expression. Highly differentially expressed nodes are assigned a positive value. 
Remaining nodes are assigned a negative value. Second, a maximally scoring network is 
computed. 
Mathematically this is equivalent to finding a maximum-weight connected subnetwork. 
If the graph contains positive and negative weighted nodes finding such MWCS is an 
NP-hard problem (cannot be computed efficiently) (Ideker et al. 2002). NP-hard 
problems are often solved with heuristic algorithms. However, heuristic methods cannot 
guarantee optimal solutions and are highly sensitive to parameter settings. A review 
over the progress in computational methods for finding functional modules is given by 
Wu et al. (2009). A major progress was introduced with an algorithm (Dittrich et al. 2008) 
that computes exact solutions for the MWCS problem in reasonable time. They 
reformulate the MWCS problem and solve it with techniques from linear programming. 
Beforehand, a scoring function allows to aggregate p-values from several studies. The p-
value distribution is decomposed into signal and noise modeled by different 
distributions. A likelihood ratio test computes positive values for highly differentially 
expressed genes and negative values for moderately or not differentially expressed genes 
belonging to the background noise. The score functions are provided as an R package 
(Beisser et al. 2010).  
Here, we deviate from the presented approach. Our main objective is to present a functional 
module whose computation is based on the knowledge from the meta-analysis. Therefore 
we consider the complete PPI network and assign all candidate genes its scores from the 
meta-analysis. Non-candidate genes are assigned a negative value. With the algorithm 
introduced by Dittrich et al. (2008) we compute a functional module. The method reduces 
the complexity of large networks to biologically relevant modules of interpretable size. 
Induced by the weighted candidate genes we compute a functional module which points to 
biological functions that are impaired in T2DM. 
The relevance of a module can be checked with gene set enrichments. Here we use an 
overrepresentation analysis (ORA) with the hypergeometric test as provided for all gene sets in 
the ConsensusPathDB (Kamburov et al. 2011). Reducing the list to Reactome pathways results 
in table 2 with an emphasis on inflammation and pyruvate metabolism pathways. Table 2 also 
shows nicely how candidate genes are complemented by closely related but non-significant 
genes. This modified set of module genes dissects the Reactome root pathways to closer defined 
metabolic or signaling entities. The ORA is also applied to the gene ontology (GO) database in 
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table 3. GO is only analysed on level 3 of its hierarchical biological process structure and 
highlights links between the functional module and several regulatory elements in metabolism. 
In fig.8 selected overrepresented pathways are highlighted in the functional module. 
 
 
Fig. 8. Reactome interaction network. The concept of a reaction where reactant A is 
transformed to product B in reaction r1 and reactant B is transformed to product C in 
reaction r2 is reformulated into a relation where reaction r1 interacts with reaction r2. The 
relation is directed towards r2 because r2 precedes r1. The resulting reaction network 
consists of several sub-networks. 
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In the following we reinterpret the Reactome (Matthews et al. 2009) pathway information 
and characterize the module by impairment of reactions. Reactome is an expert-
authored, peer-reviewed knowledge base. Reactome contains metabolic and signaling 
pathways. In metabolic pathways, proteins act as enzymes and in signaling pathways 
proteins are the main components that transfer information through interactions. We 
identify all reactions whose reactants, products or modifiers (enzymes) are part of the 
functional module and address them as covered. With the pathway information from 
Reactome we built a network (fig.9) where nodes represent reactions and edges represent 
relations between reactions: There is a directed out-going edge from a reaction to all its 
following reactions annotated in Reactome and there are directed in-coming edges to a 
reaction from all its preceding reactions. This interpretation may in mathematical terms 
be seen as a dual graph of the Reactome network. We compute shortest paths between all 
covered reactions and visualize the results in fig. 10. Nodes (covered reactions and non-
covered) lying on these paths are included in the final set of reactions. The initial 
Reactome network is reduced to those reactions which are impaired in the course of 
T2DM and those reactions that link impaired reactions. Such a network can guide future 
research: Which pathways interfere with the proper functioning of other pathways? 
What is the link between proteins that interact with each other but are involved in 
different pathways? 
 
 
Fig. 9. A) The network shows the functional module where candidate genes are marked 
with diamonds and over-represented (OR) pathways are colored. B) Nodes in functional 
module involved in OR pathways tend to interact with each other. (C) Similarly OR GO-
terms are colored in the functional module. 
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p-value q-value Pathway Root All FM Gene set 
3.3e-5 0.0022 
Alternative complement 
activation 
IIS 3 3 C3*, CFB*, CFD* 
2.0e-4 0.0087 
TRAF6 Mediated 
Induction of 
proinflammatory 
cytokines 
IIS 64 9 
APP, ATF1, IKBKG, MAPK1*, 
MAPK9*, NFKB2, NFKBIA*, 
PPP2R1B, RELA* 
3.0e-4 0.0087 
NFkB and MAP kinases 
activation mediated by 
TLR4 signaling repertoire
IIS 67 9 
4.0e-4 0.0089 TLR3 Cascade IIS 70 9 
APP, ATF1, IKBKG, MAPK1*, 
MAPK9*, NFKB2, NFKBIA*, 
PPP2R1B, RELA* 
5.0e-4 0.0089 
MyD88-independent 
cascade initiated on 
plasma membrane 
IIS 71 9 
6.0e-4 0.0089 
TRAF6 mediated NF-kB 
activation 
IIS 22 5 
APP, IKBKG, NFKB2, 
NFKBIA*, RELA* 
6.0e-4 0.0089 
TRAF6 mediated 
induction of NFkB and 
MAP kinases upon 
TLR7/8 or 9 activation 
IIS 74 9 
APP, ATF1, IKBKG, MAPK1*, 
MAPK9*, NFKB2, NFKBIA*, 
PPP2R1B, RELA* 
7.0e-4 0.0089 
MyD88 dependent 
cascade initiated on 
endosome 
IIS 75 9 
APP, ATF1, IKBKG, MAPK1*, 
MAPK9*, NFKB2, NFKBIA*, 
PPP2R1B, RELA* 
7.0e-4 0.0089 TLR7/8 Cascade IIS 75 9 
8.0e-4 0.0091 TLR4 Cascade IIS 90 10 
APP, ATF1, CD14*, IKBKG, 
MAPK1*, MAPK9*, NFKB2, 
NFKBIA*, PPP2R1B, RELA* 
9.0e-4 0.0091 
Mitochondrial Fatty Acid 
Beta-Oxidation 
ML
L 
14 4 
ACADL*, HADHB, MCEE*, 
PCCB 
9.0e-4 0.0091 
human TAK1 activates 
NFkB by 
phosphorylation and 
activation of IKKs 
complex 
IIS 24 5 
APP, IKBKG, NFKB2, 
NFKBIA*, RELA* 
0.0010 0.0091 TLR1, 2, 6, 9 Cascade IIS 79 9 
APP, ATF1, IKBKG, MAPK1*, 
MAPK9*, NFKB2, NFKBIA*, 
PPP2R1B, RELA* 
0.0018 0.0129 TLR Cascades IIS 
10
0 
10 
APP, ATF1, CD14*, IKBKG, 
MAPK1*, MAPK9*, NFKB2, 
NFKBIA*, PPP2R1B, RELA* 
0.0019 0.0129 
Viral dsRNA:TLR3:TRIF 
Complex Activates RIP1 
IIS 28 5 
APP, IKBKG, NFKB2, 
NFKBIA*, RELA* 
0.0019 0.0129 
Chylomicron-mediated 
lipid transport 
ML
L 
17 4 APOA1, LDLR*, LPL*, P4HB 
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p-value q-value Pathway Root All FM Gene set 
0.0021 0.0141 
Activated TLR4 
signalling 
IIS 86 9 
APP, ATF1, IKBKG, MAPK1*, 
MAPK9*, NFKB2, NFKBIA*, 
PPP2R1B, RELA* 
0.0022 0.0141 Lipoprotein metabolism 
ML
L 
29 5 
APOA1, LDLR*, LPL*, P4HB, 
PLTP* 
0.0043 0.0253 
Lipid digestion, 
mobilization, and 
transport 
ML
L 
48 6 
APOA1, FABP4*, LDLR*, LPL*, 
P4HB, PLTP* 
0.0049 0.0277 
Fatty acid, 
triacylglycerol, and 
ketone body metabolism 
ML
L 
82 8 
ACADL*, ACLY*, ACSL1*, 
FASN*, HADHB, MCEE*, 
MED1*, PCCB 
0.0060 0.0327 
Propionyl-CoA 
catabolism 
ML
L 
4 2 MCEE*, PCCB 
0.0075 0.0377 
Advanced glycosylation 
endproduct receptor 
signaling 
IIS 13 3 APP, LGALS3*, MAPK1* 
0.0089 0.0434 
Pyruvate metabolism 
and Citric Acid cycle 
PM 40 5 BSG*, DLD, FH*, NNT*, PDK4* 
0.0098 0.0458 
Beta oxidation of lauroyl-
CoA to decanoyl-CoA-
CoA 
ML
L 
5 2 ACADL*, HADHB 
Table 2. Pathway over-representation analysis for proteins contained in the functional 
module, restricted to root level pathways IIS, MLL and PM. The table lists Reactome 
pathways in which proteins of our functional module are enriched. All: Number of proteins 
represented in the specified pathway. FM: Number of proteins represented in the specified 
pathway and contained in the functional module. Root: Specifies the root pathway as 
defined by Reactome for the given pathway (IIS – Innate Immunity Signaling, MLL – 
Metabolism of lipids and lipoproteins and PM – Pyruvate metabolism and Citric Acid (TCA) 
cycle). Candidate genes are succeded by a star in the last column. 
5. Discussion 
Many applications have been developed based on the analyses of topological network 
properties which provide insights into the evolution, function, stability and dynamic 
responses of PPI networks (Albert 2005). Deciphering the wiring scheme and determining 
topological properties of individual nodes could help to derive protein function and 
formulate predictions about disease involvement. Special attention is drawn towards 
highly connected nodes whose removal has serious, or even lethal, consequence for the 
network. Highly connected nodes are probably evolutionarily conserved or encoded by 
essential genes (Goh et al. 2007). There is evidence that in literature-curated PPI networks 
disease genes share common topological characteristics which differ from non-disease 
genes: Hereditary disease genes selected from OMIM (Hamosh et al. 2005) have a larger 
degree, the tendency to interact with each other, more common neighbors and fast 
communication to other disease genes (Xu & Li 2006). 
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The tendency of proteins involved in the same disease to interact with each other can be 
traced to the chromosome level (Oti et al. 2006). Genes that interact with known disease 
genes have a higher likelihood of being also disease relevant. In summary, network analysis 
reveals properties of potential disease genes. There are good reasons to assume that disease 
genes are not randomly placed in the interactome.  
The meta-analysis is a valuable method for ranking genes according to their disease 
relevance. In a follow-up step we put the candidate genes from Rasche et al. into a 
functional context. We took advantage of PPI data in two ways: First, we characterized 
disease genes with respect to their topological parameters. Second, we applied an 
algorithm that channels all available PPIs into a sub-network. This subnetwork seems to 
contain relevant information about the underlying biological functions impaired in 
T2DM. The topological characterization of candidate genes reveals properties which 
distinguish them from the complete set genes: Compared to the complete set of 
candidate genes have higher node degrees (fig. 4), higher betweenness centrality 
coefficients (fig. 5), higher 2N indices (fig. 7) and shorter average distances to other 
candidate genes (fig. 6). The ten candidate genes with highest degree are: PIK3R1 (246), 
ACTB (244), RELA (236), MAPK1 (206), EIF4A2 (157), YBX1 (148), NFKBIA (119), 
TNFRSF1B (110) and B2M (108). These genes are well described in the literature. They 
are associated with different diseases. Although there is a relation between node degree 
and disease relevance we have to consider a bias towards genes where disease relevance 
and connectivity is established. The meta-analysis also identifies genes with a small node 
degree as relevant for T2DM: ACSL1, AKR1B10, AOX1, CCNI, GATM, GPD2, GPX2, 
LGMN, LRP10, NNT, P4HA1, RETN, SLC38A2, TMSB4X, YIPF5 and ZSCAN21 (all with 
node degree of one).  
Candidate genes exhibit higher betweenness centrality coefficients. Candidate genes 
with highest betweenness centrality coefficients are: ACTB (0.011), PIK3R1 (0.009), 
MAPK1 (0.008), RELA (0.007), B2M (0.005), HSPA5 (0.004), DYNLL1 (0.003), C1QBP 
(0.003), TNFRSF1B (0.003) and NFKBIA (0.003). Nodes with a high betweenness 
centrality coefficient are termed bottlenecks (Yu et al. 2007). Many shortest paths pass 
through a node with high betweenness centrality coefficient; a perturbation in a node 
with high betweenness centrality coefficient easily deranges the rest of the network. 
Betweenness centrality better accounts for the prediction of node’s essentiality in the 
network than the node degree. A perturbation in a node with a high degree which lies in 
the outer part of the network probably has less severe consequences than a node which 
lies more central in the network. Candidate genes do not differ in clustering coefficient 
and neighbourhood connectivity from the set of all genes. Direct neighbors of candidate 
genes are not more likely also candidate genes (1N index). However, the 2N index for 
candidate genes is higher than for non-candidate genes: Neighbors of neighbors of 
candidate genes are more likely also candidate genes. These results indicate that T2DM 
involves several impaired biological functions. A higher 1N index for candidate genes 
would suggest that a single biological function is perturbed. Related to the higher 2N 
index for candidate genes is the smaller average shortest paths length from a candidate 
gene to all other candidate genes. Topological parameters may not isolate disease genes 
if they are individually considered. But in this study they indicate that candidate genes 
link several biological processes as shown by the high betweenness centrality and the 
high 2N index.  
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p-value q-value Term name All FM 
1.7e-39 1.1e-36 response to organic substance 1072 65 
5.4e-30 1.7e-27 regulation of cell death 1115 49 
3.2e-29 6.7e-27 positive regulation of biological process 2465 79 
9.4e-29 1.5e-26 regulation of response to stimulus 648 40 
1.4e-27 1.7e-25 regulation of immune system process 545 38 
3.0e-27 3.1e-25 regulation of immune response 319 30 
2.1e-26 1.9e-24 response to inorganic substance 316 33 
3.3e-24 2.6e-22 programmed cell death 1321 59 
4.8e-24 3.3e-22 response to drug 341 33 
1.7e-23 1.1e-21 positive regulation of immune response 214 22 
2.7e-23 1.6e-21 response to molecule of bacterial origin 187 22 
7.9e-23 4.1e-21 response to hormone stimulus 580 43 
2.5e-22 1.2e-20 negative regulation of cell death 548 39 
4.4e-22 2.0e-20 cell differentiation 1899 67 
1.7e-21 7.0 e-20 positive regulation of macromolecule metabolic process 1109 45 
1.8e-21 7.0e-20 negative regulation of biological process 2193 76 
2.5e-21 9.2e-20 regulation of developmental process 942 44 
3.4e-21 1.2e-19 organ development 2026 71 
7.2e-21 2.4e-19 system development 2622 81 
1.0e-20 3.2e-19 antigen processing and presentation via MHC class Ib 16 3 
1.9e-20 5.7e-19 adaptive immune response 166 20 
4.7e-19 1.3e-17 
antigen processing and presentation of exogenous 
antigen 
19 4 
8.3e-19 2.3e-17 regulation of cellular process 5922 126 
1.2e-18 3.2e-17 positive regulation of cell death 613 27 
3.1e-18 7.7e-17 positive regulation of cellular metabolic process 1141 44 
1.8e-17 4.4e-16 protein complex assembly 681 42 
2.0e-17 4.7e-16 T cell mediated cytotoxicity 29 7 
2.7e-17 5.9e-16 immune effector process 269 27 
3.4e-16 7.4e-15 positive regulation of biosynthetic process 875 35 
3.9e-16 8.0e-15 cellular response to chemical stimulus 547 36 
5.0e-16 9.8e-15 macromolecular complex assembly 853 45 
5.0e-16 9.8e-15 positive regulation of immune effector process 72 14 
Table 3. GO term over-representation analysis (terms downstream to term biological process 
level 3) for genes in the functional module. 
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Next, we identified a sub-network in the complete PPI network with enrichment in 
candidate genes. The algorithm used was proposed by Dittrich et al. for the computation of 
functional modules. Candidate genes were weighted with their meta-analysis score and the 
remaining nodes in the network with a negative score. A pathway over-representation 
analysis points to the pathways Hemostasis, Innate immunity signaling, Pyruvate metabolism 
and citric acid cycle, Metabolism of lipids and lipoproteins and Metabolism of carbohydrates. Our 
results confirm a known relation between inflammation and metabolic disorders 
(Hotamisligil 2006). The link between metabolism and immune response pathways can be 
retraced to common ancestral structures (Hotamisligil 2006). The Toll-like receptor (TLR) 
pathway comprises elements which regulate metabolic and immune functions. TLR4, 
receptor for bacterial LPS and component of innate immune system acts as a sensor for free 
fatty acids (Shi et al. 2006). Free fatty acids are increased in obesity and are a probable link to 
lipid-induced insulin resistance. The functional module contains genes (RELA, NFKBIA, 
NFKB2, ATF1, MAPK1, IKBKG, MAPK9) which are activated downstream to TLR4 (Akira & 
Takeda 2004). Analysis of the functional module also reveals a link to platelet dysfunction 
(Vinik et al. 2001). 
Over-representation analysis for GO terms with root node biological function reveals terms 
lying downstream to cell death and immune response. Pathway and GO terms analysis 
suggests and supports the strong link between inflammation and T2DM. We extended this 
knowledge by annotated pathways, e.g. by introducing the notion of covered reactions. A 
covered reaction involves a protein from the functional module, either as enzyme, reactant 
or product. We suppose that an impaired covered reaction may have a negative influence on 
the network. 
Using the PPI network, a list of candidate genes could be characterized according to 
distributions of topological parameters, especially in comparison to the full set of PPI. At the 
current stage of knowledge we can only use a static PPI graph, since the complete graph is 
unknown. We assume that we already have a representative subset of PPIs in the databases. 
We pointed out that known PPIs reflect only static, sometimes artificial, settings. In these 
settings interactions depend on many factors and thus proteins may only interact under 
certain circumstances. To overcome some of these constraints the candidate genes are 
extended to a functional module using the MWCS method. Genes lacking interaction 
information are skipped and only non-candidate genes which are directly linked and are in 
direct proximity to candidates are included in the module. The functional module genes are 
related to functional entities by applying ORA to Reactome and GO gene sets. These 
databases cover far less genes than PPI networks but with much more detailed descriptions 
about the purpose of the genes within a biological context. Module genes are related to the 
discussed functional entities which shows that current knowledge is well incorporated in 
the functional module. Furthermore, Reactome was also the basis for a modified description 
of its functional content with the notation of covered reactions. This is a possible way of 
identifying several pathways which interact in a direct or indirect manner. In the case of the 
functional module it elucidates how over-represented pathways are linked in T2DM and 
which module genes possibly modulate this link. 
6. Conclusion 
Results of a single-gene meta-analysis are combined with methods from network biology. We 
have to keep in mind that PPI networks are not static but are modified for changing cellular 
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states. In the long term it does not suffice to consider topological properties alone. We have to 
elaborate on an understanding of the dynamics of PPIs. Different conditions influence 
structural rearrangements in the cell which we need to measure and depict. Computation of 
functional modules is an attempt of including additional levels to the interaction data. We see 
overlapping functions rather than a clear division in single biological sections. 
 
 
Fig. 10. A) Hierarchical view of shortest paths between all covered reactions. A covered 
reaction is shown as diamond, non-covered reaction as circle, non-covered reactions connect 
covered reactions. Over-represented pathways in the functional module are highlighted 
according to the color scheme in fig. 9. B) Genes from the functional module which are 
involved in a covered reaction. Frames with different line types in A) and B) elucidate how 
the functional module connects different pathways. 
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